等待開盤 01-30 09:30:00 美东时间
+0.790
+0.53%
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
JP Morgan analyst Tami Zakaria maintains Middleby (NASDAQ:MIDD) with a Neutral and raises the price target from $125 to $140.
01-15 03:21
The Middleby ( ($MIDD) ) has provided an announcement. On January 6, 2026, The ...
01-07 06:28
今日重点评级关注:Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从8美元升至8.25美元;Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12.5美元升至13美元
2025-12-11 10:33
U.S. stocks were mixed, with the Nasdaq Composite falling more than 100 points ...
2025-12-10 23:41
今日重点评级关注:Stifel:维持X4 Pharmaceuticals"买入"评级,目标价从7.5美元升至10美元;花旗:维持UP Fintech Holding"买入"评级,目标价从17.4美元升至17.5美元
2025-12-08 08:34
Canaccord Genuity analyst Brian McNamara maintains Middleby (NASDAQ:MIDD) with a Buy and raises the price target from $171 to $175.
2025-12-06 03:13
Middleby Corp (MIDD) sells 51% stake in Residential Kitchen business to 26North Partners LP for $540M+ upfront cash, plus $135M seller note.
2025-12-04 21:18
The Middleby Corporation ("Middleby") (NASDAQ:MIDD) today announced entry into a definitive agreement under which it will sell a 51% stake in its Residential Kitchen business to affiliates of 26North Partners LP
2025-12-04 19:33
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43